AI-generated summary
The authors compared fractional CO2 laser followed by topical tranexamic acid with the same laser followed by topical ascorbic acid in 40 adults with melasma, using a split-face design. They report that the tranexamic acid side showed somewhat greater improvement than the ascorbic acid side, with the baseline difference in vascularity noted. The authors state that more controlled, larger trials are needed.
- Participants
- 40
- Who or what was studied
- Forty adults aged 20 to 50 with melasma
- Limits stated in the abstract
- The authors note that larger, more controlled trials are required, and the abstract reports only baseline findings and a small sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Purpose
Melasma is a chronic, acquired disorder of focal hypermelanosis. It clinically presents as hyperpigmented patches over photo-exposed areas such as the face. The study aimed to evaluate the efficacy and safety of combined fractional CO2 laser with topical tranexamic acid (TA) versus combined fractional CO2 laser with topical ascorbic acid in treating patients with melasma.
Methods
Forty individuals, spanning the ages of 20 to 50, diagnosed with melasma were included in this prospective split-face comparison study. Patients were subjected to detailed medical, skin, dermoscopic, and Woods light, digital skin assessment for their grading of melasma before and after treatment. Subjects received fractional CO2 laser sessions to the affected areas before applying 10% solution of TA on the right side and 20% ascorbic acid solution on the left side.
Results
Baseline dermoscopic examination of the right side showed that 62.5% of the patients had fading of pseudo reticular network, 22.5% had fading telangiectasia, while the other 15% had no change. Considering the left side, 55% had fading of pseudo reticular network, 40% had fading telangiectasia, while the other 5% had no change. The baseline characteristics of melasma were comparable except for vascularity which was significantly higher in the right side compared to the left (p = 0.007).
Conclusion
Trans-epidermal delivery of tranexamic acid or vitamin C after low power fractional CO2 laser is a useful tool with more superiority towards the tranexamic acid treatment. More controlled larger sample trials are required to establish an optimal and effective treatment for melasma.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.